Benzinga | Aug 5, 2021 04:38PM EDT

Acorda Therapeutics Q2 EPS $(2.29) Misses $(2.09) Estimate, Sales $31.79M Beat $29.94M Estimate

Acorda Therapeutics (NASDAQ:ACOR) reported quarterly losses of $(2.29) per share which missed the analyst consensus estimate of $(2.09) by 9.57 percent. This is a 554.29 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $31.79 million which beat the analyst consensus estimate of $29.94 million by 6.16 percent. This is a 5.45 percent decrease over sales of $33.62 million the same period last year.